Guarantees of Counterparty Debt and Provision of Collateral, and Guarantee Loss Risk
First written in FY2017-Q3. 16 of 17 entries say "Mitigated", first in FY2017. Latest entry: FY2021-Q3.
The whole theme swung hardest in 2026: 5 of 11 companies on the "Worse" side.
10 other companies' latest entry also says "Mitigated".
- FY2021-Q3MitigatedAnnual report
「As of the end of the previous consolidated fiscal year, we had guaranteed ¥63 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions and had also pledged ¥45 million in time deposits as collateral for a further ¥45 million of the company's borrowings from financial institutions. Both arrangements had been resolved by the end of the third quarter of the current consolidated fiscal year. A provision for losses on guarantees had been recognized for the full balance of the company's borrowings covered by the guarantees and collateral, and the entire provision was reversed accordingly.」
The ¥63 million guarantee for the business partner and the ¥45 million collateral were resolved by the end of the third quarter, and the provision for losses on guarantees that had been recognized was fully reversed. - FY2021-Q2MitigatedAnnual report
「As of the end of the second quarter of the current consolidated fiscal year, we had guaranteed ¥50 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥63 million as of the end of the previous consolidated fiscal year).」
The amount guaranteed for the business partner declined from ¥63 million at the previous fiscal year-end to ¥50 million. The ¥45 million collateral and the provision for losses on guarantees covering the full balance of the covered borrowings remain in place. - FY2021-Q1MitigatedAnnual report
「As of the end of the first quarter of the current consolidated fiscal year, we had guaranteed ¥56 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥63 million as of the end of the previous consolidated fiscal year).」
The amount guaranteed for the business partner declined from ¥63 million at the previous fiscal year-end to ¥56 million. The ¥45 million collateral and the provision for losses on guarantees covering the full balance of the borrowings covered by the guarantee and collateral remain in place. - FY2020MitigatedAnnual report
「As of the end of the current consolidated fiscal year, we had guaranteed ¥63 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥195 million as of the end of the previous consolidated fiscal year).」
The amount guaranteed for the business partner declined from ¥195 million to ¥63 million. The ¥45 million collateral and the provision for losses on guarantees covering the full balance of the guaranteed borrowings remain in place. - FY2020-Q3MitigatedAnnual report
「As of the end of the third quarter of the current consolidated fiscal year, we had guaranteed ¥71 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥195 million as of the end of the previous consolidated fiscal year). In addition, for a further ¥45 million of the company's borrowings from financial institutions (¥45 million as of the end of the previous consolidated fiscal year), we had pledged time deposits of ¥45 million as collateral. A provision for losses on guarantees has been recognized for the full balance of the company's borrowings covered by the guarantees and collateral provided by us.」
The amount guaranteed for the business partner declined from ¥195 million at the previous fiscal year-end to ¥71 million. The ¥45 million collateral and the provision covering the full balance of the covered borrowings remain in place. - FY2020-Q2MitigatedAnnual report
「As of the end of the second quarter of the current consolidated fiscal year, we had guaranteed ¥76 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥195 million as of the end of the previous consolidated fiscal year). In addition, for a further ¥45 million of the company's borrowings from financial institutions (¥45 million as of the end of the previous consolidated fiscal year), we had pledged time deposits of ¥45 million as collateral. A provision for losses on guarantees has been recognized for the full balance of the company's borrowings covered by the guarantees and collateral provided by us.」
The amount guaranteed declined from ¥195 million at the previous fiscal year-end to ¥76 million, and a reversal of ¥118 million of the provision for losses on guarantees was recognized. The ¥45 million collateral and the provision covering the full balance remain in place. - FY2020-Q1MitigatedAnnual report
「As of the end of the first quarter of the current consolidated fiscal year, we had guaranteed ¥185 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥195 million as of the end of the previous consolidated fiscal year). In addition, for a further ¥45 million of the company's borrowings from financial institutions (¥45 million as of the end of the previous consolidated fiscal year), we had pledged time deposits of ¥45 million as collateral. A provision for losses on guarantees has been recognized for the full balance of the company's borrowings covered by the guarantees and collateral provided by us.」
The amount guaranteed for the business partner declined from ¥195 million at the previous fiscal year-end to ¥185 million. The ¥45 million collateral and the provision for losses on guarantees covering the full amount of the covered borrowings remain in place. - FY2019MitigatedAnnual report
「As of the end of the current consolidated fiscal year, we had guaranteed ¥195 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥270 million as of the end of the previous consolidated fiscal year).」
The amount guaranteed for the business partner declined from ¥270 million to ¥195 million. The ¥45 million collateral and the provision for losses on guarantees covering the full amount of the covered borrowings remain in place. - FY2019-Q3MitigatedAnnual report
「As of the end of the third quarter of the current consolidated fiscal year, we had guaranteed ¥204 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥270 million as of the end of the previous consolidated fiscal year). In addition, for a further ¥45 million of the company's borrowings from financial institutions (¥45 million as of the end of the previous consolidated fiscal year), we had pledged time deposits of ¥45 million as collateral (¥45 million as of the end of the previous consolidated fiscal year). A provision for losses on guarantees has been recognized for the full balance of the company's borrowings covered by the guarantees and collateral provided by us.」
The amount guaranteed for the business partner declined from ¥270 million at the end of the previous consolidated fiscal year to ¥204 million. The ¥45 million collateral and the provision covering the full balance of the covered borrowings remain in place. - FY2019-Q2MitigatedAnnual report
「As of the end of the second quarter of the current consolidated fiscal year, we had guaranteed ¥213 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥270 million as of the end of the previous consolidated fiscal year). In addition, for a further ¥45 million of the company's borrowings from financial institutions (¥45 million as of the end of the previous consolidated fiscal year), we had pledged time deposits of ¥45 million as collateral (¥45 million as of the end of the previous consolidated fiscal year). A provision for losses on guarantees has been recognized for the full balance of the company's borrowings covered by the guarantees and collateral provided by us.」
The amount guaranteed for the business partner declined from ¥270 million at the previous fiscal year-end to ¥213 million. The ¥45 million collateral and the provision covering the full amount of the covered borrowings remain in place. - FY2019-Q1MitigatedAnnual report
「As of the end of the first quarter of the current consolidated fiscal year, we had guaranteed ¥262 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥270 million as of the end of the previous consolidated fiscal year). In addition, for a further ¥45 million of the company's borrowings from financial institutions (¥45 million as of the end of the previous consolidated fiscal year), we had pledged time deposits of ¥45 million as collateral. A provision for losses on guarantees has been recognized for the full balance of the company's borrowings covered by the guarantees and collateral provided by us.」
The amount guaranteed declined from ¥270 million at the previous fiscal year-end to ¥262 million. The ¥45 million collateral and the provision covering the full balance of the covered borrowings remain in place. - FY2018MitigatedAnnual report
「As of the end of the current consolidated fiscal year, we had guaranteed ¥270 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥292 million as of the end of the previous consolidated fiscal year).」
The amount guaranteed for the business partner declined from ¥292 million to ¥270 million. The ¥45 million collateral and the provision for losses on guarantees covering the full balance of the covered borrowings remain in place. - FY2018-Q3MitigatedAnnual report
「As of the end of the third quarter of the current consolidated fiscal year, we had guaranteed ¥277 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥292 million as of the end of the previous consolidated fiscal year). In addition, for a further ¥45 million of the company's borrowings from financial institutions (¥45 million as of the end of the previous consolidated fiscal year), we had pledged time deposits of ¥45 million as collateral. A provision for losses on guarantees has been recognized for the full balance of the company's borrowings covered by the guarantees and collateral provided by us.」
The amount guaranteed declined from ¥292 million at the end of the previous consolidated fiscal year to ¥277 million. The ¥45 million collateral and the provision covering the full balance of the covered borrowings remain in place. - FY2018-Q2MitigatedAnnual report
「As of the end of the second quarter of the current consolidated fiscal year, we had guaranteed ¥283 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥292 million as of the end of the previous consolidated fiscal year). In addition, for a further ¥45 million of the company's borrowings from financial institutions (¥45 million as of the end of the previous consolidated fiscal year), we had pledged time deposits of ¥45 million as collateral.」
The amount guaranteed declined from ¥292 million at the previous fiscal year-end to ¥283 million. The ¥45 million collateral and the provision for losses on guarantees covering the full balance of the covered borrowings remain in place. - FY2018-Q1MitigatedAnnual report
「As of the end of the first quarter of the current consolidated fiscal year, we had guaranteed ¥287 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥292 million as of the end of the previous consolidated fiscal year). In addition, for a further ¥45 million of the company's borrowings from financial institutions (¥45 million as of the end of the previous consolidated fiscal year), we had pledged time deposits of ¥45 million as collateral. A provision for losses on guarantees has been recognized for the full balance of the company's borrowings covered by the guarantees and collateral provided by us.」
The amount guaranteed declined from ¥292 million at the previous fiscal year-end to ¥287 million. The ¥45 million collateral remains in place, and a provision for losses on guarantees has been recognized for the full balance of the covered borrowings. - FY2017MitigatedAnnual report
「As of the end of the current fiscal year, we had guaranteed ¥292.945 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥313.519 million as of the end of the previous consolidated fiscal year). In addition, for a further ¥45.000 million of the company's borrowings from financial institutions (¥45.000 million as of the end of the previous consolidated fiscal year), as described in Note 2 above, we had pledged time deposits of ¥45.000 million as collateral.」
The amount guaranteed declined from ¥313.519 million to ¥292.945 million. The ¥45.000 million collateral remains in place, and a provision for losses on guarantees has been recognized for the full amount of the covered borrowings. - FY2017-Q3First statedAnnual report
「As of the end of the first nine months of the current consolidated fiscal year, we had guaranteed ¥300.421 million of borrowings by our business partner, ㈱バイオマトリックス研究所, from financial institutions (¥313.519 million as of the end of the previous consolidated fiscal year). In addition, for a further ¥45.000 million of the company's borrowings from financial institutions (¥45.000 million as of the end of the previous consolidated fiscal year), we had pledged time deposits of ¥45.000 million as collateral. A provision for losses on guarantees has been recognized for the full balance of the company's borrowings covered by the guarantees and collateral provided by us.」
Disclosed a guarantee for ¥345.421 million of borrowings by a business partner and collateral of ¥45.000 million, with a provision for losses on guarantees recognized for the full balance of borrowings covered by the guarantee and collateral. There is no indication that a default or guarantee loss has actually occurred.